Ticker APYX – Apyx Medical – sales, description, marketcap – Tickerday.com

APYX

Apyx Medical

–

Index: NASDAQ; Sector: Healthcare; Industry: Medical Equipment & Supplies;

Marketcap: 160.47M; Volume: 3.39K; AvgVol 3m: 71.73K; Beta: 0.61;

Cost estimate:

P/E: –; EPS: -0.49; EPS growth quarter/prev quarter: -6.60%;

EPS growth this year: -78.00%; EPS growth past 5 years: 10.80%;

EPS ttm: -0.49;

P/S: 6.62; P/B: 2.66; P/Cashflow: ; P/FCF: ;

Sales: 25.34M; Sales growth quarter/prev quarter: -34.80%; Sales growth past 5 years: 0.40%;

Profitability:

Gross Margin: 63.90%; Profit Margin: -66.20%; Operating Margin: -95.60%;

ROA – return on assets: -20.20%; ROE – return on equity: -23.50%; LT Debt/Equity: 0.01; Total Debt/Equity: 0.01;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.10%; Insider Transactions:;

Institutional Ownership: 54.50%; Institutional Transactions: 1.21%;

Data update: 07/10/2020.